{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:17:35Z","timestamp":1788218255575,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canada Graduate Scholarship from the Canadian Institutes of Health Research"},{"name":"Graduate Studentship from the Women and Children\u2019s Health Research Institute of the University of Alberta"},{"name":"Alberta Innovates Summer Studentship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.peptides.2019.170228","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:35:34Z","timestamp":1575549334000},"page":"170228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Cardiovascular biology of the GIP receptor"],"prefix":"10.1016","volume":"125","author":[{"given":"Amanda A.","family":"Greenwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadin J.","family":"Chahade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-5707","authenticated-orcid":false,"given":"John R.","family":"Ussher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170228_bib0005","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9922","key":"10.1016\/j.peptides.2019.170228_bib0010","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0015","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2217\/fca.12.68","article-title":"The impact of current and novel anti-diabetic therapies on cardiovascular risk","volume":"8","author":"Ussher","year":"2012","journal-title":"Future Cardiol."},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cmet.2013.04.008","article-title":"Pharmacology, physiology, and mechanisms of incretin hormone action","volume":"17","author":"Campbell","year":"2013","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.peptides.2019.170228_bib0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molmed.2016.03.005","article-title":"Reappraisal of GIP pharmacology for metabolic diseases","volume":"22","author":"Finan","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.peptides.2019.170228_bib0030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/er.2018-00117","article-title":"Targeting the Incretin\/Glucagon system with triagonists to treat diabetes","volume":"39","author":"Capozzi","year":"2018","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0035","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.beem.2009.03.001","article-title":"Therapeutic potential for GIP receptor agonists and antagonists","volume":"23","author":"Irwin","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0045","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cmet.2011.12.019","article-title":"G-protein-coupled receptors in intestinal chemosensation","volume":"15","author":"Reimann","year":"2012","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International Union of Pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacol. Rev."},{"issue":"23","key":"10.1016\/j.peptides.2019.170228_bib0065","doi-asserted-by":"crossref","first-page":"22297","DOI":"10.1074\/jbc.M500540200","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.3997","article-title":"TCF1 links GIPR signaling to the control of beta cell function and survival","volume":"22","author":"Campbell","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.peptides.2019.170228_bib0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.peptides.2019.170228_bib0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.peptides.2019.170228_bib0085","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.mcna.2004.04.011","article-title":"Impact of obesity on the risk of heart failure and survival after the onset of heart failure","volume":"88","author":"Kenchaiah","year":"2004","journal-title":"Med. Clin. North Am."},{"issue":"8","key":"10.1016\/j.peptides.2019.170228_bib0090","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","article-title":"Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes","volume":"54","author":"Gault","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0095","doi-asserted-by":"crossref","first-page":"E1746","DOI":"10.1152\/ajpendo.00460.2007","article-title":"GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet","volume":"293","author":"McClean","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bph.13323","article-title":"Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors","volume":"173","author":"Sparre-Ulrich","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0105","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/db16-0758","article-title":"Inhibition of gastric inhibitory polypeptide receptor signaling in adipose tissue reduces insulin resistance and hepatic steatosis in high-fat diet-fed mice","volume":"66","author":"Joo","year":"2017","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.peptides.2019.170228_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040156","article-title":"GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"209","key":"10.1016\/j.peptides.2019.170228_bib0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"10160","key":"10.1016\/j.peptides.2019.170228_bib0120","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.peptides.2019.170228_bib0125","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M609088200","article-title":"Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/endo.140.1.6464","article-title":"Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin","volume":"140","author":"McIntosh","year":"1999","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.peptides.2019.170228_bib0135","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"Nagashima","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035683","article-title":"Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice","volume":"7","author":"Nogi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170228_bib0145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molmet.2018.05.014","article-title":"The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE(-\/-) mice by blocking monocyte\/macrophage activation","volume":"14","author":"Kahles","year":"2018","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/db15-0122","article-title":"Glucose-dependent insulinotropic polypeptide stimulates osteopontin expression in the vasculature via Endothelin-1 and CREB","volume":"65","author":"Berglund","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.peptides.2019.170228_bib0155","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI200318141","article-title":"Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice","volume":"112","author":"Bruemmer","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.peptides.2019.170228_bib0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s003800200005","article-title":"Development of atherosclerosis in osteopontin transgenic mice","volume":"16","author":"Chiba","year":"2002","journal-title":"Heart Vessels"},{"issue":"6","key":"10.1016\/j.peptides.2019.170228_bib0165","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.peptides.2019.170228_bib0170","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2017.11.003","article-title":"Inactivation of the glucose-dependent insulinotropic polypeptide receptor improves outcomes following experimental myocardial infarction","volume":"27","author":"Ussher","year":"2018","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.peptides.2019.170228_bib0175","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1253\/circj.CJ-16-0152","article-title":"Suppressive effects of glucose-dependent insulinotropic polypeptide on cardiac hypertrophy and fibrosis in angiotensin II-Infused mouse models","volume":"80","author":"Hiromura","year":"2016","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0180","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1210\/en.2018-00004","article-title":"GLP-1 receptor expression within the human heart","volume":"159","author":"Baggio","year":"2018","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.peptides.2019.170228_bib0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molmet.2014.04.009","article-title":"Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection","volume":"3","author":"Ussher","year":"2014","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.peptides.2019.170228_bib0190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.peptides.2019.170228_bib0195","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbalip.2016.02.011","article-title":"Lipotoxicity in obesity and diabetes-related cardiac dysfunction","volume":"1861","author":"Zlobine","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"4\u20135","key":"10.1016\/j.peptides.2019.170228_bib0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10741-011-9259-x","article-title":"Role of ACE2 in diastolic and systolic heart failure","volume":"17","author":"Wang","year":"2012","journal-title":"Heart Fail. Rev."},{"issue":"19","key":"10.1016\/j.peptides.2019.170228_bib0205","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.peptides.2019.170228_bib0210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.peptides.2019.170228_bib0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.peptides.2019.170228_bib0220","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Investigators, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119302062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119302062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:27:21Z","timestamp":1759310841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119302062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":44,"alternative-id":["S0196978119302062"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170228","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular biology of the GIP receptor","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170228"}}